Photo of promotional displays, with a picture from the ENDO2024 poster session

Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group

If you're wondering, yes, @endocrinesociety.bsky.social will use your pictures for promo material 😂 #ENDO2025

Pretty cool to have @nrimpact.bsky.social folks featured:
@profriggins.bsky.social
@zmadake2.bsky.social
@ayeshashafi.bsky.social
@cittellylab.bsky.social
Drs Cordoba-Chacon & Treviño

Looking forward to receiving some of these manuscripts. #JES

Journals Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Notice to Authors with the NIEHS Journal, Environmental Health Perspectives (EHP) | We welcome submissions or transfers of manuscripts now in process at EHP: #JES (Open Access, clinical and basic), and #Endocrinology (basic). Fees can be waived. Email publications@endocrine.org: bit.ly/2yCrRBi

Thank you Sean for the shout out🙏🏻🙏🏻🙏🏻

Thanks Becca🙏🏻🙏🏻🙏🏻

A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasiv... Matthew J Sikora, Julie H Ostrander; A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasive lobular carcinoma, Jo

@jostrander.bsky.social and I had the opportunity to write a commentary on @profriggins.bsky.social latest work in JES - @zmadake2.bsky.social - looking toward really cool implications for understanding and leveraging the unique metabolism of lobular breast cancer.

academic.oup.com/jes/advance-...